Insights into colistin-mediated fluorescence labelling of bacterial LPS

Saurodeep Mandal1, Dipanwita Patra2, Sukhendu Mandal2

  • 1Department of Chemistry, Siksha Bhavana, Visva-Bharati Santiniketan 731235 West Bengal India prithidipa.sahoo@visva-bharati.ac.in saurodeep@outlook.com gourabkanti.das@visva-bharati.ac.in.

RSC Advances
|January 18, 2024
PubMed

Insights

Researchers developed a novel fluorescent sensor to visualize how colistin interacts with lipopolysaccharides (LPS) in bacteria. This helps understand drug resistance mechanisms in multidrug-resistant infections.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Gram-negative bacterial infections pose a growing threat due to antimicrobial resistance.
  • Colistin, a last-resort antibiotic, is losing efficacy against multidrug-resistant strains.
  • Colistin targets bacterial lipopolysaccharides (LPS) to destabilize the cell membrane.

Purpose of the Study:

  • To understand the interaction mechanism between colistin and bacterial LPS.
  • To develop a method for labeling LPS to study colistin binding.
  • To investigate structural changes in bacteria upon colistin exposure.

Main Methods:

  • Utilized a novel fluorescent chemosensor (naphthaldehyde appended furfural - NAF) to label LPS.
  • Employed computational modeling (3D structure, quantum mechanics, molecular dynamics) to predict colistin-LPS binding.
  • Applied fluorescence microscopy and FE-SEM to observe bacterial morphology changes.

Main Results:

  • The NAF sensor successfully labeled bacterial LPS, showing fluorescence signals.
  • Computational studies provided insights into the potential binding modes of colistin with LPS.
  • Microscopic analyses revealed morphological alterations in colistin-sensitive and resistant *Salmonella typhi*.

Conclusions:

  • The developed fluorescent sensor enables visualization of colistin-LPS interactions.
  • Understanding these interactions is crucial for combating antimicrobial resistance.
  • This approach aids in developing strategies against multidrug-resistant Gram-negative bacteria.